Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
Executive Women’s Initiative

Event on 5 May 2014: Prof. Dr. Connie Eaves

Prof. Dr. Connie Eaves

(BA & MSc, Queens University, Canada; PhD University of Manchester, UK) was a co-founder of the Terry Fox Laboratory in 1981, and has served both as its Deputy Director and Director. She has received numerous scholarships and awards, including election as a Fellow of the Royal Society of Canada, receipt of the NCI (Canada) Robert L. Noble Prize for Excellence in Cancer Research, the American Society of Hematology Henry Stratton Medal for Life- time Achievement and the 2013 Rowley Prize of the International CML Foundation. During her PhD, she discovered that two cell populations contribute to the generation of antibody responses, heralding the subsequent recognition of B and T cells. She has since contributed seminal advances to our understanding of normal and leukemic blood stem and progenitor cells. Over the last decade, she has also become an expert in breast stem cells. She has published more than 450 papers and continues to direct a dynamic research group. She is a major protagonist of excellence in training, having personally supervised more than 90 graduate students and post-MD and post-PhD fellows. She has also previously served in many senior leadership positions (including President of the International Society for Experimental Hematology, President of the former National Cancer Institute of Canada, Vice-President of Research at the BC Cancer Agency, member of the Board of Genome Canada an ISSCR), and she continues to be active in promoting and advising several collaborative translational and interdisciplinary research programs and networks.

to top
powered by webEdition CMS